Howard Horn Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Howard Horn is CFO of Vir Biotechnology, Inc.. Currently has a direct ownership of 230,712 shares of VIR, which is worth approximately $1.69 Million. The most recent transaction as insider was on Feb 23, 2023, when has been sold 2,248 shares (Common Stock) at a price of $25.97 per share, resulting in proceeds of $58,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 231K
0% 3M change
0% 12M change
Total Value Held $1.69 Million

Howard Horn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2023
SELL
Open market or private sale
$58,380 $25.97 p/Share
2,248 Reduced 0.96%
230,712 Common Stock
Feb 17 2023
SELL
Open market or private sale
$61,302 $25.29 p/Share
2,424 Reduced 1.03%
232,960 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
-
35,000 Added 12.94%
235,384 Common Stock
Feb 17 2022
SELL
Open market or private sale
$76,408 $31.93 p/Share
2,393 Reduced 1.18%
200,384 Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 10.98%
202,777 Common Stock

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
Chief Financial Officer
HH

Howard Horn

CFO
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR